Effect of buffer systems and preservatives in the composition of eye drops on safe and long-term treatment of patients with dry eye disease

Authors

  • S.I. Kosuba Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
  • L.P. Tutchenko Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
  • O.V. Tumanova Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
  • M.V. Skovron Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine

DOI:

https://doi.org/10.22141/2309-8147.7.3.2019.179618

Keywords:

dry eye disease, preservative, buffer systems

Abstract

During the last years, tear substitutes have been considered as a basic drug treatment for dry eye disease. Their effect is directed to compensation of watery component of the tear and increase of the tear film stability. Main focus is made on preservatives and buffer systems. The questions of preservatives effect on ocular surface and the possibility of using alternative means are highlighted. Data of preclinical and clinical researches are presented to prove the advantages of the exclusion of preservatives from eye drops and the level of risk of the complications if the drug containing preservative is instilled for a long period.

Downloads

Download data is not yet available.

References

Александрова О.И., Околов И.Н., Хорольская Ю.И., Блинова М.И., Чураков Т.K. Оценка влияния бензалкония хлорида на цитотоксичность глазных капель Неттацин и Тобрекс в условиях in vitro. Cовременные технологии в офтальмологии. 2016. № 3. С. 163-166.

Александрова О.И., Околов И.Н., Хорольская Ю.И., Панова И.Е., Блинова М.И. Оценка цитотоксичности слезо­заместительных препаратов с использованием системы in vitro. ­Офтальмология. 2017. Т. 14(1). С. 59-64.

Александрова О.И., Околов И.Н., Хорольская Ю.И., Панова И.Е., Блинова М.И. Оценка цитотоксичности in vitro как критерий рационального выбора слезозаместительных препаратов. Офтальмология. 2018. Т. 15(2). С. 167-175.

Бржеский В.В., Сомов Е.Е. Синдром «сухого глаза»: болезнь цивилизации. Окулист. 2002. № 9(10). С. 8-9.

Бржеский В.В., Егорова Г.Б., Егоров Е.А. Синдром «сухого глаза» и заболевания глазной поверхности: клиника, диагностика, лечение. М.: ГЭОТАР-Медиа, 2016. 464 с.

Бржеский В.В. Глаукома и синдром «сухого глаза». М.: ООО «Компания БОРГЕС», 2018. 228 с.

Лебедев О.И., Калижникова Е.А., Яворский А.Е. Механизмы и результаты действия бензалкония хлорида на ткани глаза. РМЖ. Клиническая офтальмология. 2013. № 2. С. 63.

Смердова А.В. Характеристика протекторного действия гепарина при введении этанола и пчелиного яда экспериментальным животным. Автореф. дис... канд. биол. наук. Нижний Новгород, 2011.

Ткаченко Н.В., Астахов С.Ю. Опыт применения «Хилопарина» в клинической практике. Офтальмологические ведомости. 2014. № 4. С. 54-62.

Шранге Н.Ф. Офтальмология. Восточная Европа. 2015. № 2. С. 129-135.

Allen M.J., White G.F., Morby A.P. The response of Esche­richia coli to exposure to the biocide polyhexamethylene biguanide. ­Microbiology. 2006. Vol. 152. Р. 989-1000.

Aragona P. et al. Long term treatment with sodium hyalu­ronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br. J. Ophthalmol. 2002. Vol. 86 (2). P. 181-184.

Bachman W.G., Wilson G. Essential ions for the maintenance of the corneal epithelial surface. Invest. Ophthalmol. Vis. Sci. 1985. Vol. 26. P. 1484-1488.

Baudouin C., de Lunardo C. Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br. J. Ophthalmol. 1998. Vol. 82. Р. 39-42.

Baudouin C. et al. In vitro studies of antiglaucomatous pro­staglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost. Invest. Ophthalmol. Vis. Sci. 2007. Vol. 48. № 9. P. 4123-4128.

Baudouin C. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma. Acta Ophthalmol. 2008. Vol. 86. № 7. P. 716-726.

Baudouin C., Labbe A., Liang H., Pauly A., Brignole-Baudouin F. Preservatives in eye drops: the good, the bad and the ugly. Prog. Retin. Eye Res. 2010. Vol. 9. P. 312-334.

Baudouin C., Aragona Р., Messmer E.M. et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul. Surf. 2013. Vol. 11. № 4. P. 246-258.

Becquet F., Goldschild M., Moldovan M.S., Etta­iche M., Gastaud P., Baudouin C. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr. Eye Res. 1998. Vol. 17 (4). Р. 419-425.

Bozac E., Brief G., Margesco F., Munteanu H. Heparin in thetreatment of ocular burns caused by bases. Ann. Ocul. (Paris). 1967. Vol. 200(6). Р. 693-700.

Bron A. Duke-Elder Lecture. Prospects for the dry eye. Trans. Ophthalmol. Soc. 1985. Vol. 104. P. 801-826.

Bron A.J., De Paiva C.S., Chauhan S.K. et al. TFOS DEWS II pathophysiology report. Ocular Surface. 2017. Vol. 15. Р. 438-510.

Carney L.G., Hill R.M. Human tear pH. Diurnal va­riations. Arch. Ophthalmol. 1976. Vol. 94. P. 821-824.

Chung S.H., Lee S.K., Cristol S.M., Lee E.S., Lee D.W., Seo K.Y., Kim E.K. Impact of short-term exposure of commercial eyedrops preserved with benzalkonium chloride on precorneal mucin. Mol. Vis. 2006. Vol. 12. Р. 415-421.

Codling C.E., Hann A.C., Maillard J.Y., Russell A.D. An investigation into the antimicrobial mechanisms of action of two contact lens biocides using electron microscopy. Cont Lens Anterior Eye. 2005. Vol. 28. Р. 163-168.

Cohen G.M. Caspases: the executioners of apoptosis. Biochem J. 1997. Vol. 326. P. 1-16.

Craig J.P., Tomlinson A. Effect of age on tear osmola­lity. Optom. Vis. Sci. 1995. Vol. 72. P. 713-717.

Debbasch C., Pisella P.J., Rat P. et al. Cytotoxicity evaluation of three tear substitutes used in the treatment of dry eye syndromes. J. Fr. Ophthalmol. 2000. Vol. 23(9). P. 863-869.

De Saint Jean M. et al. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells Invest. Ophthalmol. Vis. Sci. 1999. Vol. 40. № 3. P. 619-630.

Elder D., Crowley P. Antimicrobial Preservatives Part One: Choosing a Preservative System. American Pharmaceutical Review. 2012. URL: http://www. americanpharmaceuticalreview.com/

Featured-Articles/38886-Antimicrobial Preservatives-Part-One-Choosing-a-Preservative-System/.

Epstein S.P. et al. Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells. J. Ocul. Pharmacol. Ther. 2009. Vol. 25. № 5. P. 415-424.

Fassihi A.R., Naidoo N.T. Irritation associated with tear-replacement ophthalmic drops. A pharmaceutical and subjective investigation. S. Afr. Med J. 1989. Vol. 75. Р. 233-235.

Freeman P., Kahook M. Preservatives in Topical Ophthalmic Medications: Historical and Clinical Perspectives. Expert Review of Ophthalmology. 2009. Vol. 4(1). Р. 59-64.

Gobbels M., Spitznas M. Influence of artificial tears on corneal epithelium in dry-eye syndrome. Graefes Arch. Clin. Exp. ­Ophthalmol. 1989. Vol. 227. Р. 139-141.

Grant W.M. New treatment for calcific corneal opacities. Arch. Ophthalmol. 1952. Vol. 48. Р. 681-685.

Grant W.M., Schuman J.S. Toxicology of the eye. 4th Edition. Springfield, IL, USA: Charles C. Thomas Publisher Ltd, 1993. Р. 167.

Grant R., Ajello M., Vlass E. Salt water or high tech? A look at two new rinsing solutions for contact lenses. Optician. 1996. Vol. 212. Р. 38-41.

Haddox J.L., Pfister R.R., Yuille Barr D. The efficacy of topical citrate after alkali injury is dependent on the period of time it is admi­nistered. Invest. Ophthalmol. Vis. Sci. 1989. Vol. 30. Р. 1062-1068.

Hamano T., Horimoto K., Lee M., Komemushi S. Sodium hyaluronate eye drops enhance tear film stability. Jap. J. Ophthalmol. 1996. Vol. 40 (1). P. 62-65.

Herreras J.M., Pastor J.C., Calonge M., Asensio V.M. Ocular surface alteration after long-term treatment with an anti­glaucomatous drug. Ophthalmology. 1992. Vol. 99. Р. 1082-1088.

Houlsby R., Ghajar M., Chavez G. Antimicrobial acti­vity of boratebuffered solutions. Antimicrob. Agents Chemo­ther. 1986. Vol. 29. Р. 803-806.

Jones L., Downie L.E., Korb D. et al. TFOS DEWS II Mana­gement and therapy report. Ocular Surface. 2017. Vol. 15. Р. 575-628.

Kahook M.Y., Noecker R.J. Comparison of corneal and conjunctival changes after dosing of Travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears. Cornea. 2008. Vol. 27(3). Р. 339-343.

Kaštelan S., Tomić М., Salopek-Rabatić J. et al. Diagnostic procedures and management of dry eye. Biomed. Res. Int. 2013. Art. 309723.

Labbe A., Pauly A., Liang H., Brignole-Baudouin F., Martin C., Warnet J.M., Baudouin C. Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study. J. Ocul. Pharmacol. Ther. 2006. Vol. 22. Р. 267-278.

Lehmann D., Cavet M., Richardson M. Nonclinical safety evaluation of boric acid and a novel borate-buffered contact lens multi-purpose solution, Biotrue™ multipurpose solution. Cont. Lens Anterior Eye. 2010 Dec.

Li J. Apoptosis in an interleukin-2-dependent cyto­toxic T lymphocyte cell line is associated with intracellular acidification. J. Biol. Chem. 1995. Vol. 270. P. 3203-3211.

Liang H. et al. Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits. Mol. Vis. 2008. Vol. 31. № 14. P. 204-216.

Masschelein W.J. Chlorine Dioxide, Chemistry and Environmental Impact of Oxychlorine Compounds. Ann Arbor (Ed.). MI, USA: Science, 1979. Р. 50-55.

Michels R., Michels S., Kaminski S. Effect of combined topical heparin and steroid on corneal neovascularization in children. Ophthalmic Surg Lasers Imaging. 2012. Vol. 43(6). Р. 452-458.

Mueller-Lierheim. Traenenersatz- und Kontaktlinsenbenetzungsloesungen. Köln Biermann, ed. Aktuelle Kontaktologie. 2015. Р. 8-15.

Nikolic L., Friend J., Taylor S., Thoft R.A. Inhibition of vascularization in rabbit corneas by heparin: cortisone pellets. Invest. Ophthalmol. Vis. Sci. 1986. Vol. 27(4). Р. 449-456.

Parker A.V., Williams R.N., Paterson C.A. The effect of so­dium citrate on the stimulation of polymorphonuclear leukocytes. Invest. Ophthalmol. Vis. Sci. 1985. Vol. 26. Р. 1257-1261.

Patel S. The management of dry-eye problems. Optician. 2001. Vol. 221. Р. 26-32.

Paterson C.A., Williams R.N., Parker A.V. Characteristics of polymorphonuclear leukocyte infiltration into the alkali burned eye and the influence of sodium citrate. Exp. Eye. Res. 1984. Vol. 39. Р. 701-708.

Pauly A., Brignole-Baudouin F., Labbe A. et al. New tools for the evaluation of toxic ocular surface changes in the rat. Invest. Ophthalmol. Vis. Sci. 2007. Vol. 48. Р. 5473-5483.

Pisella P.J., Fillacier K., Elena P.P., Debbasch C., Baudouin C. Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Ophthalmic. Res. 2000. Vol. 32. Р. 3-8.

Pisella P.J., Debbasch C., Hamard P. et al. Conjunctival proin ammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest. ­Ophthalmol. Vis. Sci. 2004. Vol. 45. Р. 1360-1368.

Purite, Package insert. Bio-Cide International Inc. OK, USA, 1998. Р. 1-3.

Rapisarda A., Battaglia F., Mauceri F. Evaluation of the ocular tolerability and efficacy of a monodose hypotonic viscoelastic tear substitute (SVS20), in comparison with a commercially available artificial tear based on hydroxypropylmethylcellulose and Dextran 70 (HPMC) in patients with keratoconjunctivitis sicca or Sjogren’s syndrome (a study of the osmolarity of the lachrymal film). Syracuse, Italy: Ophthalmo­logy Department Ospedale Civile “Umberto I”; 1994 Oct. 24. Report No.: SVS20-01.02.

Rolando M., Brezzo V., Giordano G., Campagna P., Burlando S., Calabria G. The effect of different benzal­konium chloride concentrations on human normal ocular surface. Van Bijsterveld O., Lemp M., Spinelli D. (Eds.). The Lacrimal System. Amsterdam: Kugler and Ghedini Publications, 1991.

Rolando M. Evaluation of the ocular tolerability and effi­cacy of a monodose hypotonic viscoelastic tear substitute (SVS20), in comparison with a commercially available artificial tear based on hydroxypropylmethylcellulose and Destran 70 (HPMC), in patients with keratoconjunctivitis sicca or Sjogren’s syndrome. Genova, Italy: Ophthalmology Clinic of the University of Genova, 1994.

Rosenthal R., Henry C., Stone R., Schlech B. Anatomy of a regimen: consideration of multipurpose solutions during non-compliant use. Cont. Lens Anterior Eye. 2003. Vol. 26(1). Р. 17-26.

Rimmer S. An open, non-comparative, exploratory trial on the performance profile of a contact lens lubricant (SVS20) after single instillation in symptomatic contact lens wearers: University of Wales, Cardiff. Dept of Optometry and Vision Sciences; 2000 July 26. Report No.: SVS20-98-01.

Samar K. Basak Preservatives and Ocular Surface Diseases. Kerala Journal of Ophthalmology. 2016. Vol. 18(4). Р. 311-316.

Schrage N., Frentz M., Reim M. Changing the composition of buffered eye-drops prevents undesired side effects. Br. J. Ophthalmol. 2010. Vol. 94. Р. 1519-22.

Schrage N., Frentz M., Spoeler F. The Ex Vivo Eye Irritation Test (EVEIT) in evaluation of artificial tears: Purite-preserved versus unpreserved eye drops. Graefes Arch. Clin. Exp. Ophthalmol. 2012 Sep. Vol . 250(9). Р. 1333-1340.

Sengor T. et al. Contact lens related dry eye and ocular surface changes in long term soft contact lens wearers. 9th Congress the international society of dacryology and dry eye. 16–18 May 2008, Istanbul. P. 53-54.

Sjogren Н. Zur Kenntnis der Keratoconjunctivitis sicca. Keratitis filiformis bei hypofunktion der Tranendrusen. Acta Ophthal. 1933. № 11. Suppl. 2. P. 1-151.

Sjogren H. Keratoconjunctivitis sicca — ein Teil symptom eines grosseren Symptomenkomplexes. Ber. Versammlung Deutsch. Ohthalm. Gesellschaft. 1936. Vol. 51. P. 122-127.

Teping Ch., Bischoff G. Treatment of sicca syndrome — effective and well-tolerated also with contact lenses. Drug Report: Hyaluronic acid. 2010. Vol. 4(2). 15 p.

The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf. 2007. Vol. 5. № 2. P. 75-92.

Dry Eye WorkShop. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf. 2007. Vol. 5. Р. 93-107.

The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf. 2007. Vol. 5. № 2. P. 163-178.

Tiffany J.M. Viscoelastic properties of human tears and polymer solutions. Adv. Exp. Med. Bio. 1994. Vol. 350. P. 267-270.

Tripathi B.J., Tripathi R.C. Cytotoxic effects of benzalkonium chloride and chlorobutanol on human corneal ­epithelial cells in vitro. Lens Eye Toxic. Res. 1989. Vol. 6. Р. 395-403.

Tomlinson A., Trees G.R. Effect of preservatives in artificial tear solutions on tear film evaporation. Ophthalmic. Physiol. Opt. 1991. Vol. 11. Р. 48-52.

Tu E. Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives. Saudi J. Ophthalmol. 2014. Vol. 28(3). Р. 182-187.

Whitson J., Petroll W. Corneal epithelial cell viability follo­wing exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents. Adv. Ther. 2012. Vol. 29. Р. 874-88.

Wilson W.S., Duncan A.J., Jay J.L. Effect of benzal­konium chloride on the stability of the precorneal tear film in rabbit and man. Br. J. Ophthalmol. 1975. Vol. 59. Р. 667-669.

Wolffsohn J.S., Arita R., Chalmers R. et al. TFOS DEWS II Diagnostic Methodology report. Ocular Surface. 2017. Vol. 15. 539-574.

Yeh S., Song X.J., Farley W. et al. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest. ­Ophthalmo. Vis. Sci. 2003. Vol. 44. P. 124-129.

Yoon S.Y., Kim J.Y., Kim E.S., Kim S.Y., Kim M.J., ­Tchah H. Subconjunctival injection of low-molecular-weight heparin-taurocholate 7 inhibits corneal neovascularization. Cornea. 2013. Vol. 32(11). Р. 1488-1492.

Yoshimura H., Hosokawa K. Studies on the mechanism of salt and water secretion from the lacrimal gland. Jpn. J. Physiol. 1963. Vol. 15. P. 303-318.

Published

2021-09-28

Issue

Section

Exchange of Experience

Most read articles by the same author(s)